Ping An Net Income Over Time
| PASW Stock | 0.22 0.02 10.00% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Ping An Performance and Ping An Correlation. What growth prospects exist in Textile Manufacturing sector? Can Ping capture new markets? Factors like these will boost the valuation of Ping An. Anticipated expansion of Ping directly elevates investor willingness to pay premium valuations. Valuation analysis balances hard financial data with qualitative growth assessments. While each Ping An valuation metric matters, prioritizing which indicators carry greater predictive weight remains essential.
Investors evaluate Ping An Biomedical using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Ping An's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investment professionals apply varied valuation frameworks to compute inherent worth and acquire positions when market prices trade at discounts to calculated value. External factors like market trends, sector rotation, and investor psychology can cause Ping An's market price to deviate significantly from intrinsic value.
It's important to distinguish between Ping An's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Ping An should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Ping An's market price signifies the transaction level at which participants voluntarily complete trades.
Cross Equities Net Income Analysis
Compare Ping An Biomedical and related stocks such as Li Bang International, PS International, and Primega Group Holdings Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LBGJ | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 2.7 M | 848.1 K | 616.8 K | (1.4 M) | (1 M) | (912.2 K) | (866.6 K) |
| PSIG | 3.7 M | 3.7 M | 3.7 M | 3.7 M | 3.7 M | 3.7 M | 3.7 M | 3.7 M | 3.7 M | 3.7 M | 3.7 M | 12.5 M | 2.4 M | (733.3 K) | (4.8 M) | (4.3 M) | (4.1 M) |
| ZDAI | 33.9 K | 33.9 K | 33.9 K | 33.9 K | 33.9 K | 33.9 K | 33.9 K | 33.9 K | 33.9 K | 33.9 K | 33.9 K | 2 M | 1.2 M | 1.1 M | (7 M) | (6.3 M) | (6 M) |
| OFAL | 174.3 K | 174.3 K | 174.3 K | 174.3 K | 174.3 K | 174.3 K | 174.3 K | 174.3 K | 174.3 K | 174.3 K | 174.3 K | 174.3 K | 174.3 K | (93.2 K) | (714.7 K) | (643.2 K) | (611.1 K) |
| TLIH | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 5 M | 7.1 M | 1.9 M | 2.2 M | 4.3 M |
| ARTW | (2 M) | 2.7 M | 1.6 M | 935.2 K | (557.8 K) | (426.2 K) | (1.4 M) | (3.3 M) | (1.4 M) | (2.1 M) | 212.6 K | 97.8 K | 267 K | 307.4 K | 1 M | 931.5 K | 978.1 K |
| GRNQ | (22.3 K) | (22.3 K) | (22.3 K) | (22.3 K) | (133.7 K) | (383.8 K) | (222.3 K) | (2.3 M) | (8.5 M) | (1.3 M) | (3.8 M) | (14.4 M) | (6.4 M) | 1.1 M | (715.3 K) | (643.8 K) | (675.9 K) |
| INLF | 36.6 K | 36.6 K | 36.6 K | 36.6 K | 36.6 K | 36.6 K | 36.6 K | 36.6 K | 36.6 K | 36.6 K | 36.6 K | 36.6 K | 537.6 K | 1.4 M | 1.6 M | 1.8 M | 971.6 K |
| VRME | (1.1 M) | (670 K) | (1.2 M) | (16.4 M) | (7.9 M) | (2.3 M) | (1.6 M) | (3.4 M) | (2.9 M) | (2.5 M) | (5.9 M) | 3.6 M | (14.4 M) | (3.4 M) | (3.8 M) | (3.4 M) | (3.6 M) |
| LSH | (2.9 K) | (2.9 K) | (2.9 K) | (2.9 K) | (2.9 K) | (2.9 K) | (2.9 K) | (2.9 K) | (2.9 K) | (2.9 K) | (2.9 K) | (2.9 K) | 741 K | (225.3 K) | (5.2 M) | (4.7 M) | (4.5 M) |
Ping An Biomedical and related stocks such as Li Bang International, PS International, and Primega Group Holdings Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Ping An Biomedical financial statement analysis. It represents the amount of money remaining after all of Ping An Biomedical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Ping An Biomedical | PASW |
Specialization | Consumer Cyclical, Textile Manufacturing |
| Business Address | China United Plaza, |
| Exchange | NASDAQ Exchange |
null 0.22
Additional Tools for Ping Stock Analysis
When running Ping An's price analysis, check to measure Ping An's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ping An is operating at the current time. Most of Ping An's value examination focuses on studying past and present price action to predict the probability of Ping An's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ping An's price. Additionally, you may evaluate how the addition of Ping An to your portfolios can decrease your overall portfolio volatility.